Wayne, NJ, United States of America

Nadhamuni G Nerella



Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Wayne, NJ (US) (1999 - 2000)
  • Bridgewater, NJ (US) (2003)

Company Filing History:


Years Active: 1999-2003

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Nadhamuni G Nerella: Innovator in Pharmaceutical Tablet Technology

Introduction

Nadhamuni G Nerella is a notable inventor based in Wayne, NJ (US). He has made significant contributions to the field of pharmaceutical technology, particularly in the development of tablet formulations. With a total of 5 patents to his name, Nerella's work has had a meaningful impact on the industry.

Latest Patents

Nerella's latest patents include a tablet coating composition that features a mixture of sodium alginate and a polyvinylpyrrolidone-vinyl acetate copolymer. This composition may also include hydroxypropylmethyl cellulose and/or hydroxypropyl cellulose. Another significant patent is a synergistic filler composition designed for making pharmaceutical tablets that achieve sufficient hardness at low compression force. This innovation minimizes friability and prevents damage to the tablet during further processing, without requiring a substantial increase in tablet size. The filler composition comprises a PVP-VA copolymer and microcrystalline cellulose.

Career Highlights

Nerella is currently associated with Isp Investments Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the quality and efficiency of tablet formulations, which are crucial for effective drug delivery.

Collaborations

Nerella has collaborated with talented individuals such as Jenn S Shih and Anil Menon, contributing to a dynamic work environment that fosters innovation and creativity.

Conclusion

Nadhamuni G Nerella's contributions to pharmaceutical technology through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of effective and efficient tablet formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…